# Stephen Reeders

> Stephen Reeders is a startup investor at MVM Life Science Partners. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [MVM Life Science Partners](https://shizune.co/investors/profile/mvm-life-science-partners)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/stephen-reeders

Stephen Reeders is a startup investor at MVM Life Science Partners. Steve Reeders founded MVM in 1997. Prior to setting up MVM, he was responsible for early-stage healthcare investments at Saunders, Karp & Megrue in New York City. Between 1988 and 1993 Steve was an Investigator of the Howard Hughes Medical Institute at the Boyer Center for Molecular Medicine at Yale, where he was also an Associate Professor ofMedicine and Genetics. He has published more than 50 papers on the molecular genetics of human disease.Steve has been involved in starting several US biotechnology companies and was acting CEO at UpToDate In Medicine in Wellesley, Mass. He practised medicine at the John Radcliffe Hospital, Churchill Hospital, Guys Hospital, St Thomas's Hospital, Hammersmith Hospital and the Institute of Neurology, Queen Square before taking up research into molecular genetics at Oxford University. He has a degree in Natural Sciences from Cambridge and a Doctorate in medicine from Oxford and is a member of the Royal College of Physicians of England.Steve is a member of the boards of Beacon Endoscopic Ltd, Cheetah Medical, Inc., and Pulmagen Therapeutics Ltd. He was previously a director of BioVex Group, Inc., Biomedix, Inc., Cara Therapeutics, Inc., Clavis Pharma ASA, Domantis Ltd, Gendaq Ltd, Momenta Pharmaceuticals, Inc., New Chemical Entities, Inc., Nova Science Ltd, Sangamo Biosciences, Inc., Spherics, Inc., UpToDate, Inc. Xention Ltd and Vascular Pathways, Inc.

## About MVM Life Science Partners

VC Fund · London, United Kingdom

MVM manages four funds totaling more than US$700 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.

5 contacts available at MVM Life Science Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Anna Norrington | Head of Investor Communications | https://shizune.co/investors/profile/anna-norrington |
| Hugo Harrod | Partner | https://shizune.co/investors/profile/hugo-harrod |
| Neil Akhurst | Finance Partner | https://shizune.co/investors/profile/neil-akhurst |
| Stephen Reeders | Founder & Managing Partner | https://shizune.co/investors/profile/stephen-reeders |
| Stephen Reeders | Founder & Managing Partner | https://shizune.co/investors/profile/dr-stephen-reeders |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co